2023 has brought major changes in the clinical research technology industry. As research sites face a backlog of clinical trials, they’re becoming more selective with which studies they take on.

Clinical research company IQVIA (NYSE: IQV) reported Q3 CY2025 results , with sales up 5.2% year on year to $4.1 billion. The ...

During this session, the panelists discussed how stakeholders in the clinical research market can leverage new technologies to better identify subjects, optimize trial conduct and reduce costs. For ...

The AI platform goes through unstructured medical records to surface eligible trials, allowing clinical research teams to ...

Clinical trials are critical to the future of the healthcare system. While already a well-established activity, clinical trial protocols and compliance are always evolving. This continual ...

Learn how increasing system complexity and patient-facing technologies are creating new burdens for clinical trial sites—and what vendors and sponsors can do to streamline operations and improve ...

There is an explosion of innovation in drug development. In 2023, the FDA approved 55 novel drugs. There were five approved gene therapies for rare diseases, including the first-ever FDA-approved ...

Get key insights from DaVita's Q3 2025 earnings: updated guidance, tech investments, and outlook amid healthcare policy shifts.

Increasing costs, complexity, regulatory demands and decentralization of clinical trials are driving PE dealmakers to invest more in designers of clinical research technologies. Tech providers and ...

Thermo Fisher said on Wednesday it would buy privately held data management company Clario for up to $9.4 billion, ...

At Inventus, we believe in creating solutions that simplify the complexities of device provisioning in the world of clinical trials. Founded in 2020, we are the world’s only Original Equipment ...

In the world of clinical trials, patient recruitment is an ongoing challenge. | In the world of clinical trials, patient ...